In vivo modulators of antibody kinetics

被引:11
作者
Jekunen, A
Kairemo, K
Karnani, P
机构
关键词
D O I
10.3109/02841869609101640
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to summarize the effect of in vivo modulation of antibody kinetics and to present new data on the in vivo effect of the cell membrane active detergent Tween 80 and the cytokine interleukin-2 (IL-2) on the accumulation and clearance of a radioactive antibody, Mice bearing Lewis lung carcinoma xenografts and rats bearing DMBA-induced mammary carcinomas were studied after injecting I-125 labeled IgG(1) monoclonal antibody (3c4c7g6) raised against a tyrosine kinase receptor protein Tie, Expression of Tie is known to be abundant in vascular endothelia and possibly related to malignant angiogenesis, Tween 80 was administered intratumorally (0.04% of tumor volume), whereas IL-2 was administered intraperitoneally. In the Lewis lung tumor model, the absolute tumor uptake varied between 2 and 5% ID/g, and maximum uptake was achieved after 24 h with Tween, and after 48 h without Tween, Tween manipulation did not increase the uptake in any normal organ, but it enhanced antibody clearance from the blood, In the DMBA rat model, IL-2 had no effect on blood clearance, but enhanced the uptake of Tie antibody into the tumor from 2.5-0.9 to 4.5-0.4% ID/g at 48 h, These data indicate that antibody biodistribution and pharmacokinetics can be modulated by a surface detergent and a cytokine, giving decreased exposure to critical organs, and increased uptake into the tumor, This type of manipulation provides an opportunity to optimize radio-immunotherapy.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 26 条
[1]  
BLUMENTHAL RD, 1994, CANCER-AM CANCER SOC, V73, P1083, DOI 10.1002/1097-0142(19940201)73:3+<1083::AID-CNCR2820731348>3.0.CO
[2]  
2-3
[3]   RADIOIMMUNOTHERAPY OF CANCER - CLINICAL-STUDIES AND LIMITING FACTORS [J].
DYKES, PW ;
BRADWELL, AR ;
CHAPMAN, CE ;
VAUGHAN, ATM .
CANCER TREATMENT REVIEWS, 1987, 14 (02) :87-106
[4]  
EPENETOS AA, 1986, CANCER RES, V46, P3183
[5]   INCREASED VASCULAR-PERMEABILITY IN ORGANS MEDIATED BY THE SYSTEMIC ADMINISTRATION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 IN MICE [J].
ETTINGHAUSEN, SE ;
PURI, RK ;
ROSENBERG, SA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (03) :177-188
[6]   IMMUNOPHOTODIAGNOSIS OF COLON CARCINOMAS IN PATIENTS INJECTED WITH FLUORESCEINATED CHIMERIC ANTIBODIES AGAINST CARCINOEMBRYONIC ANTIGEN [J].
FOLLI, S ;
WAGNIERES, G ;
PELEGRIN, A ;
CALMES, JM ;
BRAICHOTTE, D ;
BUCHEGGER, F ;
CHALANDON, Y ;
HARDMAN, N ;
HEUSSER, C ;
GIVEL, JC ;
CHAPUIS, G ;
CHATELAIN, A ;
VANDENBERGH, H ;
MACH, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :7973-7977
[7]  
GOLDENBERG DM, 1988, ARCH PATHOL LAB MED, V112, P580
[8]  
GRIDLEY DS, 1991, CANCER RES, V51, P1515
[9]   HISTAMINE, LEUKOTRIENE-C4 AND INTERLEUKIN-2 INCREASE ANTIBODY UPTAKE INTO A HUMAN CARCINOMA XENOGRAFT MODEL [J].
HENNIGAN, TW ;
BEGENT, RHJ ;
ALLENMERSH, TG .
BRITISH JOURNAL OF CANCER, 1991, 64 (05) :872-874
[10]  
JAIN RK, 1988, CANCER RES, V48, P2641